JuLib | Articles & more

Characterisation of 120I for PET imaging

Herzog, H.
2005

“...2005...”

2

Der kombinierte Einsatz von FET PET und MRT verbessert die Diagnostik bei Gliomen

Pauleit, D.
2005

“...2005...”

3

Bevorzugte Hirnanreicherung von D-Serien im Vergleich zu L-Serien

Bauer, D.
2005

“...2005...”

4

Ist die FET-PET der FDG-PET in der Diagnostik von Plattenepithelkarzinomen aus dem Kopf-Hals-Bereich überlegen?

Stoffels, G.
2005

“...2005...”

5

O-(2-[18F]fluoroethyl]-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

Pauleit, D.
2005

Brain, 128 (2005) S. 678 - 687

“...2005...”

6

Characterization of the short-lived non-pure positron emitter 120I for PET imaging

Herzog, H.
2005

“...2005...”

7

Preferred stereoselective brain uptake of D-serine - a modulator of glutamatergic neurotransmission

Bauer, D.
2005

Nuclear medicine and biology, 32 (2005) S. 793 - 797

“...2005...”

8

New nuclear data for production of 124I via 3He- and alpha-particle induced reactions on natSb and 121Sb

Hassan, R. J.
2005

Journal of labelled compounds and radiopharmaceuticals, 48 (2005) S. S112

“...2005...”

9

New nuclear data for production of 124I via 3He- and alpha-particle induced reactions on natSb and 121Sb

Hassan, R. J.
2005

“...2005...”

10

2alpha,3beta-tropane-derivatives: New fluorinated ligands for the dopamine transporter

Drewes, B.
2005

Journal of labelled compounds and radiopharmaceuticals, 48 (2005) S. S91

“...2005...”

11

2alpha,3beta-Tropane-derivatives: New fluorinated ligands for the dopamine transporter

Drewes, B.
2005

“...2005...”

12

18F-labelled amino acids, a lifetime story with perspectives

Coenen, H. H.
2005

Nuclear medicine review, 8 (2005) S. 2 - 3

“...2005...”

13

18F-labelled amino acids, a lifetime story with perspectives

Coenen, H. H.
2005

“...2005...”

14

Experimental measurements and nuclear model calculations on the excitation functions of natCe(3He,xn)and 141Pr(p,xn) reactions with special reference to production of the therapeut...

Hilgers, K.
2005

Radiochimica acta, 93 (2005) S. 553 - 560

“...2005...”
OpenAccess

15

Labelling of manganese-based magnetic resonance imaging (MRI) contrast agents with the positron emitter 51Mn, as exemplified by manganese-tetraphenyl-porphin-sulfonate (MnTPPS4)

Klein, A. T. J.
2005

Applied radiation and isotopes, 62 (2005) S. 711 - 720

“...2005...”

16

O-(2-[18F]-L-tyrosine PET in the clinical evaluation of primary brain tumours

Weckesser, M.
2005

European Journal of Nuclear Medicine and Molecular Imaging, 32 (2005) S. 422 - 429

“...2005...”

17

A new radio-TLC method for the quantifiction of [18F]altanserin in human plasma

Bier, D.
2005

Journal of labelled compounds and radiopharmaceuticals, 48 (2005) S. S261

“...2005...”

18

Ist die FET-PET in der Diagnostik von Plattenepithelkarzinomen aus dem Kopf-Hals-Bereich überlegen?

Stoffels, G.
2005

Nuklearmedizin, 44 (2005) S. A47

“...2005...”

19

New production routes for some therapeutic radionuclides

Spahn, I.
2005

Journal of labelled compounds and radiopharmaceuticals, 48 (2005) S. S106

“...2005...”

20